Abstract
Women at high inherited risk of ovarian cancer are offered risk-reducing salpingo-oophorectomy (RRSO) from age 35 to 45 years. Although potentially life-saving, RRSO may induce symptoms that negatively affect quality of life and impair long-term health. Clinical care following RRSO is often suboptimal. This scoping review describes how RRSO affects short- and long-term health and provides evidence-based international consensus recommendations for care from preoperative counselling to long-term disease prevention. This includes the efficacy and safety of hormonal and non-hormonal treatments for vasomotor symptoms, sleep disturbance and sexual dysfunction and effective approaches to prevent bone and cardiovascular disease.
Original language | English (US) |
---|---|
Pages (from-to) | 1437-1450 |
Number of pages | 14 |
Journal | BJOG: An International Journal of Obstetrics and Gynaecology |
Volume | 130 |
Issue number | 12 |
DOIs | |
State | Published - Nov 2023 |
Keywords
- BRCA1
- BRCA2
- early menopause
- hormone replacement therapy
- hot flushes
- ovarian cancer
- risk-reducing salpingo-oophorectomy
- sexual function
- surgical menopause
ASJC Scopus subject areas
- Obstetrics and Gynecology